TipRanks
Go Ultimate55% OFF

Curanex Pharmaceuticals Inc. (CURX) Income Statement

Curanex Pharmaceuticals Inc. Income Statement

Last quarter (Q2 2026), Curanex Pharmaceuticals Inc.'s total revenue was $0.00. In Q2, Curanex Pharmaceuticals Inc.'s net income was $-3.29M. See Curanex Pharmaceuticals Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23
$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00
$ 4.24M$ 365.06K$ 19.30K
Depreciation and Amortization$ 79.40K$ 0.00$ 1.81K
$ -4.14M$ -290.39K$ -17.48K
$ -4.24M$ -365.06K$ -19.30K
$ 13.97K$ 3.56K$ 100.00
$ -4.23M$ -361.51K$ -19.20K
$ -4.23M$ -361.51K$ -19.20K
Per Share Metrics
Basic EPS$ -2.98$ -0.26$ -0.01
Diluted EPS$ -2.98$ -0.26$ -0.01
Weighted Average Shares Outstanding1.42M1.39M1.39M
Weighted Average Shares Outstanding (Diluted)1.42M1.39M1.39M

Currency in USD

Curanex Pharmaceuticals Inc. Earnings and Revenue History

-4.5M-3M-1.5M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202320242025RevenueEarningsProfit Margin